Search
for
Sort by
Research 931–960 of 1000+
- Clinical use of 5α-reductase inhibitors
- FINASTERIDE INHIBITS 5?-REDUCTASE ACTIVITY IN HUMAN DERMAL FIBROBLASTS: PREDICTION OF ITS THERAPEUTIC APPLICATION IN ANDROGEN-RELATED SKIN DISEASES
- Association between stress and bilateral symmetrical alopecia in free-ranging Formosan macaques in Mt. Longevity, Taiwan
- Dutasteride: A Review of its Use in the Management of Prostate Disorders
- Paternal Finasteride Treatment Can Influence the Testicular Transcriptome Profile of Male Offspring—Preliminary Study
- WARFARIN-INDUCED ALOPECIA: A RARE CASE REPORT
- Biotransformation of Finasteride (MK-0906) by Selenastrum capricornutum (Green Algae)
- Hormonal Therapy for Acne
- SUMMARIES OF PAPERS
- Functional Ingredient Mapping in PCOS Formulations: Hormonal Excess
- Non-classical Congenital Adrenal Hyperplasia Presenting With Severe Androgenic Alopecia: A Case Report
- Studying the relationship betweenSerum Copper levels and Vitamin D in Alopecia Areata patients with Controls in India
- Prostate Specific Antigen as Predictive Factor for Androgenemia in Women
- 5 Alpha - Reductase and Metabolic Syndrome in PCOS Patients
- Epicardial fat thickness in children with classic congenital adrenal hyperplasia
- 5α- Reductase Inhibitors in Prostate Cancer: An Overview
- 192 MicroRNAs and their regulatory interactions in the human hair follicle
- Hair loss in men
- 9. Immunology and Genetics
- NEW PROPRIETARY BRANDS: Gabapentin
- NEW PROPRIETARY BRANDS: Cephalexin
- New drugs: Agalsidase beta
- NEW FORMULATIONS: Sodium cromoglycate
- NEW PROPRIETARY BRANDS: Cefaclor monohydrate
- NEW FORMULATIONS: Glatiramer acetate
- National scientific medical meeting 1996 abstracts
- Westwood Carolina Conference on Clinical Dermatology
- Balding man.
- Self-medication by Jockeys
- Repurposing of approved cardiovascular drugs